About
About Dishman Carbogen Amcis Limited
Dishman Carbogen Amcis Limited provides contract research and manufacturing services for the pharmaceutical and healthcare industries worldwide. The company operates through Contract Research and Manufacturing Services and Marketable Molecules segments. It offers cholesterol and vitamin D analogs; generic active pharmaceutical ingredients for diagnostics, ophthalmic treatments, laxatives, organophosphate antidotes; ammonium, phosphonium; quats, phosphoranes, and wittig reagents; cholesterol and lanolin-related products; sterile injectables; and softgel formulations, as well as hand and body wash, sanitisers, and antiseptics. The company was founded in 1983 and is headquartered in Ahmedabad, India. Dishman Carbogen Amcis Limited is a subsidiary of Adimans Technologies LLP.
Visit company website
5 years, 4 months ago
Dishman Carbogen Amcis Limited is currently in a long term uptrend where the price is trading 34.2% above its 200 day moving average.
From a valuation standpoint, the stock is 81.2% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.9.
Dishman Carbogen Amcis Limited's total revenue sank by 13.6% to $5B since the same quarter in the previous year.
Its net income has dropped by 148.9% to $-161M since the same quarter in the previous year.
Finally, its free cash flow grew by 2.3% to $2B since the same quarter in the previous year.
Based on the above factors, Dishman Carbogen Amcis Limited gets an overall score of 3/5.